scholarly journals Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004

2012 ◽  
Vol 14 (S3) ◽  
Author(s):  
LT Hiraki ◽  
CH Feldman ◽  
J Liu ◽  
GS Alarcón ◽  
MA Fischer ◽  
...  
Keyword(s):  
Lupus Nephritis ◽  
Renal Disease ◽  
Renal Biopsy ◽  
End Stage Renal Disease ◽  
Prescribing Practices ◽  
The Us ◽  
Medication Prescribing ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals End-stage renal disease due to lupus nephritis among children in the US, 1995-2006

2011 ◽  
Vol 63 (7) ◽  
pp. 1988-1997 ◽  
Author(s):  
Linda T. Hiraki ◽  
Bing Lu ◽  
Steven R. Alexander ◽  
Tamara Shaykevich ◽  
Graciela S. Alarcón ◽  
...  
Keyword(s):  
Lupus Nephritis ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
The Us ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006

2011 ◽  
Vol 63 (6) ◽  
pp. 1681-1688 ◽  
Author(s):  
Karen H. Costenbader ◽  
Amrita Desai ◽  
Graciela S. Alarcón ◽  
Linda T. Hiraki ◽  
Tamara Shaykevich ◽  
...  
Keyword(s):  
Lupus Nephritis ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
The Us ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Palliation Versus Dialysis for End-Stage Renal Disease in the Oldest Old: What are the Considerations?

2017 ◽  
Vol 10 ◽  
pp. 117822421773508
Author(s):  
Lyle S Walton ◽  
Gregory D Shumer ◽  
Björg Thorsteinsdottir ◽  
Theodore Suh ◽  
Keith M Swetz
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Oldest Old ◽  
Functional Decline ◽  
Symptom Burden ◽  
Vulnerable Population ◽  
Management Approach ◽  
The Us ◽  
Stage Renal Disease ◽  
End Stage

As the US population continues to age, new cases of end-stage renal disease (ESRD) in individuals, aged 85 years or older (the oldest old), are increasing. Many patients who begin hemodialysis despite questionable benefit may struggle with high symptom burden and rapid functional decline. This article reviews the history regarding the funding and development of the Medicare ESRD program, reviews current approaches to the oldest old with ESRD, and considers strategies to improve the management approach of this vulnerable population.

scholarly journals Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease

2017 ◽  
Vol 2 (5) ◽  
pp. 905-912 ◽  
Author(s):  
Andrés Urrestarazú ◽  
Gabriela Otatti ◽  
Ricardo Silvariño ◽  
Mariela Garau ◽  
Ruben Coitiño ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Lupus Nephritis ◽  
Renal Disease ◽  
Clinical Features ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Abstract MP10: Increasing Obesity Prevalence in the United States End-stage Renal Disease Population

Circulation ◽  
2018 ◽  
Vol 137 (suppl_1) ◽  
Author(s):  
Brittany Shelton ◽  
Deanna McWilliams ◽  
Rhiannon D Reed ◽  
Margaux Mustian ◽  
Paul MacLennan ◽  
...  
Keyword(s):  
United States ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
The United States ◽  
Obesity Prevalence ◽  
The Us ◽  
Prevalence Of Obesity ◽  
Stage Renal Disease ◽  
End Stage ◽  
Esrd Patients

Background: Obesity has become a national epidemic, and is associated with increased risk for comorbid diseases including end-stage renal disease (ESRD). Among ESRD patients, obesity may improve dialysis-survival but decreases likelihood of transplantation, and as such, obesity prevalence may directly impact growth of the incident dialysis population. Methods: Incident adult ESRD patients with complete body mass index (BMI, kg/m 2 ) data were identified from the United States Renal Data System from 01/01/1995-12/31/2010 (n=1,822,598). Data from the Behavioral Risk Factor Surveillance System of the Centers for Disease Control and Prevention (n=4,303,471) represented the US population when weighted. Trends in BMI and obesity classes I (BMI of 30-34.9), II (BMI of 35-39.9), and III (BMI ≥40) were examined by year of dialysis initiation. Trends in median BMI slope were compared between the ESRD and US populations using linear regression. Results: Median BMI of ESRD patients in 1995 was 24.2 as compared to 28.0 in 2010, a 15.7% increase, while the US population’s median BMI increased from 24.2 in 1995 to 25.6 in 2010, a 5.8% increase. Comparable trends were noted with respect to prevalence of obesity classes I, II, and III (Table). BMI increase among the ESRD population was significantly more rapid than among the US population (β: 0.15, 95% CI: 0.14-0.17, p<0.001) (Figure). Conclusion: The median BMI of ESRD patients and prevalence of obesity among ESRD patients is increasing more rapidly than the US population. Given the increased dialysis-survival and decreased likelihood of transplantation associated with obesity, healthcare costs will likely increase, and thus, future research should be directed at examining medical expenditures.

Sign in / Sign up

Export Citation Format

Share Document